-
Yang Sheng leads delegation to attend ICMRA summit in ROK
Yang Sheng, deputy commissioner of China's National Medical Products Administration (NMPA), led a delegation to Seoul, the Republic of Korea (ROK), to attend the summit and plenary meeting of the International Coalition of Medicines Regulatory Authorities (ICMRA) from Nov 2 to 5, 2026.
-
Lei Ping leads delegation to attend 9th CIIE
From Nov 4 to 6, Lei Ping, deputy commissioner of the National Medical Products Administration (NMPA), led a delegation to attend the 9th China International Import Expo (CIIE) in Shanghai.
-
Huang Guo meets acting director of WHO’s Regulation and Prequalification Department
On Nov 2, Huang Guo, Commissioner of China's National Medical Products Administration (NMPA), met in Beijing with a delegation led by Hiiti Sillo, acting director of the Regulation and Prequalification Department of the World Health Organization (WHO), and Martin Taylor, WHO representative to China.
- Announcement of the National Medical Products Administration, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control and Prevention Administration on Issuing the Good Clinical Practice (No. 50, 2026)
- Good Clinical Practice for Drugs (2026 Revision): Questions and Answers
- Work Procedure for the Protection of Drug Regulatory Data
- Announcement of the National Medical Products Administration, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control and Prevention Administration on Issuing the Good Clinical Practice (No. 50, 2026)
- Good Clinical Practice for Drugs (2026 Revision): Questions and Answers
- Work Procedure for the Protection of Drug Regulatory Data







